Overview
Marco Milioli practices practicing medicine in Parma, Italy.
Mr. Milioli is highly rated in 1 condition, according to our data. His clinical expertise encompasses Inborn Renal Aminoaciduria and Lysinuric Protein Intolerance.
He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Marco Milioli
Is Marco Milioli a top-rated expert for Inborn Renal Aminoaciduria?
MediFind is an objective health platform that identifies experts based on real-world data. Marco Milioli is classified as an Advanced expert for Inborn Renal Aminoaciduria, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Marco Milioli participate in research or clinical trials?
Yes. Marco Milioli has published 11 articles and abstracts on conditions like Inborn Renal Aminoaciduria. You can view a list of Marco Milioli's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Inborn Renal AminoaciduriaMr. Milioli isAdvanced. Learn about Inborn Renal Aminoaciduria.
- Experienced
- Lysinuric Protein IntoleranceMr. Milioli isExperienced. Learn about Lysinuric Protein Intolerance.